ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...

HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

If you've been around long enough, you will encounter some bumps in the road. This is true for The Hershey Company ( HSY ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...